Shandong Weigao (01066) Announces Repurchase of 1,112,000 H Shares

Bulletin Express01-30

Shandong Weigao Group Medical Polymer Company Limited (stock code: 01066) disclosed that on 30 January 2026 it repurchased 1,112,000 H shares on the Hong Kong Stock Exchange at prices ranging from HKD 4.97 to HKD 5.24, for a total consideration of HKD 5,616,580. After the repurchase, the number of issued shares (excluding treasury shares) stood at 4,482,205,924, while treasury shares increased to 40,126,400.

According to the information, the repurchase was executed under a mandate granted on 27 May 2025, which authorizes the company to repurchase up to 451,560,392 shares. So far, 33,478,000 shares have been repurchased under this mandate, representing 7.4138% of the company’s then-issued shares (excluding treasury shares). A moratorium period for any new issue of shares or sale or transfer of treasury shares is in effect until 01 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment